Some insights into previous outbreaks of human coronaviruses may be useful in explaining the comparatively 'low' numbers of COVID-19 infections and mortality in people with HIV in South Africa.
Academic rigour, journalistic flair
Articles on TB
Displaying 1 - 20 of 58 articles
COVID-19 has stretched South Africa's public health services to capacity. In response, the services have increased their capacity through innovation.
The redirection of resources to COVID-19 has enormous consequences for the provision of healthcare services for other diseases, in particular, HIV programmes.
A century ago, Australians were battling another pandemic, tuberculosis, with public health measures many will find familiar today.
The study of two hospitals was a first for researching the microbiology of the built environment in South Africa – a multi-disciplinary approach to understanding how to design healthier buildings.
Scientists need greater understanding of the bacterium's basic biology, as well as more about how it is spread from one individual to the next.
There are many questions left unanswered because the outbreak is still in an early stage.
In some communities, over a quarter of the children were misclassified as iron replete whereas they were iron deficient.
Obstacles to getting more people with TB treated extend beyond cost. It starts with locating people at greatest risk and expanding preventive treatment programmes.
Bioinformatics can be applied to a range of problems, such as understanding the genome sequence of organisms or coming up with new drugs.
Global health researchers, funders and journals are not walking the talk on equity, diversity and inclusion.
Many of the most fundamental aspects of TB disease remain unknown. For example, after exposure to the organism that causes TB, why do only some people get infected and only some of those fall ill?
Rapid population ageing has prompted researchers to study disease trends in older South Africans. The aim is to understand the role that specific health conditions play in ageing among rural people.
Treating infectious diseases is a huge challenge because patients often fail to take the medicine for the long duration, especially for tuberculosis. Now there's a new device that may help.
What should be done to ensure that the SDGs actually change countries' development trajectories? Here are four practical steps.
The push to end TB requires significant investment into the research and development of new diagnostics and treatments.
Tuberculosis kills more people globally than any other infectious disease. A human-rights approach and investment in quality care are essential to ending the global epidemic.
New research shows that the treatment of drug resistant-TB can be reduced from the current duration of 20 to 24 months to less than a year.
TB outside the lungs accounted for 14% of TB cases recorded globally in 2017.
In Southern Africa, high rates of HIV infection have been the primary driver of TB
Job Board
-
ACADEMIC SPECIALIST (TUBERCULOSIS)
-
Research Fellow - Asphalt Materials for Sustainable Pavements
-
Learning and Development Manager
-
Senior Lecturer/Associate Professor in Endodontics
-
Dean, ANU College of Asia and the Pacific
Top contributors
-
Director of Global Health & Professor, McGill University
-
Faculty Member, Africa Health Research Institute; Associate professor, UCL
-
Associate Professor, Melbourne Health
-
Head of the Centre of Excellence for Biomedical TB Research, University of the Witwatersrand
-
Associate Professor in Paediatrics and Child Health, University of Sydney
-
Head of the Immunology Research Group at the Division of Molecular Biology & Human Genetics, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Stellenbosch University
-
Head of the Division of Pulmonology, University of Cape Town
-
Senior Lecturer, School of Computing and Information Systems, University of Melbourne; Senior Research Fellow, Doherty Institute for Infection and Immunity, University of Melbourne
-
Professor of Clinical Infectious Diseases, Director Sydney Institute for Emerging Infectious Diseases and Biosecurity, University of Sydney
-
Professor of Medicine and Professor of Immunology, University of Sydney
-
Professor of Population and Family Health, Brac University
-
Deputy Executive Director, International Centre for Diarrhoeal Disease Research
-
Deputy Program Director, Health Security, Burnet Institute
-
Lecturer, Centre for Advancing Journalism, University of Melbourne
-
Researcher, Center for Social Science and Global Health, University of Amsterdam
